All manuscripts
Publications Other G-Rex®24 Well Plate G-Rex®6 Well Plate

Improving cytokine-induced killer cell expansion using a gas-permeable culture method for clinical-scale production

Published Journal Asian Pacific Journal of Allergy and Immunology

Share
No image preview

Overview

This paper compares CIK cell expansion in G-Rex® devices vs standard plates. G-Rex® 24-well and 6-well plates were used. G-Rex® resulted in significantly higher expansion and IFN-g secretion, supporting clinical-scale production.

What this paper found

Expanding cytokine-induced killer (CIK) cells in a gas-permeable G-Rex® plate produced more cells than a conventional 24-well plate, with similar phenotype and cytotoxicity. From 1 × 10^6 PBMCs per well (three healthy donors), 14-day G-Rex® 24-well cultures reached 110 × 10^6 total cells and 17 × 10^6 NK-T cells, versus 73 × 10^6 and 9 × 10^6 in standard plates, and secreted more IFN-γ. Cell subsets, activation markers and killing of K562 and Kasumi leukemia cells did not differ significantly. Seeding 30 × 10^6 PBMCs in a G-Rex® 6-well plate yielded over 1 × 10^9 cells per run (mean 5.1 × 10^9) in 14 days. A GMP donor-derived product given to a patient with AML relapsed after allogeneic transplant was followed by 2 years of complete remission.

Note: Clinical activity is described in a single patient treated on a compassionate-use basis rather than in a clinical trial; the bench comparison used cells from three healthy donors.

The gas-permeable culture method could expand cultured CIK cells in all samples to more than 1 × 10^9 cells from only 30 × 10^6 PBMCs after 14 days. — Supannikar Tawinwung, Suparat Tudsamran, Rattapoom Thaiwong, Thiti Asawapanumas, Kitsada Wudhikarn, Chantiya Chanswangphuwana, Nattiya Hirankarn, Udomsak Bunworasate, Koramit Suppipat, Asian Pacific Journal of Allergy and Immunology

Study details

Authors
Supannikar Tawinwung, Suparat Tudsamran, Rattapoom Thaiwong, Thiti Asawapanumas, Kitsada Wudhikarn, Chantiya Chanswangphuwana, Nattiya Hirankarn, Udomsak Bunworasate, Koramit Suppipat
Institution
Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand · Clinical Excellence Center for Comprehensive Cancer, King Chulalongkorn Memorial Hospital, Bangkok, Thailand · Division of Hematology and Research Unit in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand · Cancer Immunotherapy Excellence Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand · Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Chulalongkorn University, Bangkok, Thailand · Department of Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand · Cellular Immunotherapy Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Journal
Asian Pacific Journal of Allergy and Immunology
Year
2022
PMID / PMC
PMID: 36592164
G-Rex® model(s)
G-Rex®24 Well Plate, G-Rex®6 Well Plate
Cell type(s)
Other
Application area
Hematologic malignancy
Study phase
Preclinical

How G-Rex® was used

PBMCs were seeded in a G-Rex® 24-well plate (2 cm² per well) at 1 × 10^6 cells in 8 mL of medium with IFN-γ, then given anti-CD3 and IL-2, and grown for 14 days with one partial medium change on day 7, alongside a conventional 24-well plate. For clinical-scale production, 5 × 10^6 PBMCs per well in 30 mL were seeded across a G-Rex® 6-well plate (10 cm² per well; 30 × 10^6 cells in total) and cultured for 14 days. The same G-Rex® 6-well protocol was used under GMP to make a 3.6 × 10^9-cell donor CIK product for a patient with relapsed AML.

Note: In the G-Rex® 24-well arm, IL-2 was added every 3 to 4 days, but the medium was exchanged only once, on day 7, during the 14-day culture.

Explore related

Full citation

Tawinwung S, Tudsamran S, Thaiwong R, et al. Improving cytokine-induced killer cell expansion using a gas-permeable culture method for clinical-scale production. Asian Pac J Allergy Immunol. 2025;43(3):673-684.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →